The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.30
Bid: 2.60
Ask: 4.00
Change: 0.19 (6.11%)
Spread: 1.40 (53.846%)
Open: 3.11
High: 0.00
Low: 0.00
Prev. Close: 3.11
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

7 Sep 2018 16:40

DIRECTOR DEALINGS: Proteome Sciences Non-Exec Director Buys Shares

LONDON (Alliance News) - Biopharmaceutical research firm Proteome Sciences PLC said Friday Non-Executive Director Martin Diggle purchased 469,866 shares at a price of 3.60 pence each on acquired a

Read more
14 Aug 2018 17:58

DIRECTOR DEALINGS: Proteome Sciences non-Exec Director Acquires Shares

LONDON (Alliance News) - Proteome Sciences PLC on Tuesday said Non-Executive Director Martin Diggle purchased shares in the science research company.In a transaction on Monday, Diggle at a

Read more
9 Aug 2018 14:50

DIRECTOR DEALINGS: Fund Linked To Proteome Director Buys Shares

LONDON (Alliance News) - Proteome Sciences said Thursday that Vulpes Life Sciences Fund purchased 1.4 million shares in the company on Tuesday at 3.50 pence each.Vulpes now has a 19.6% in a

Read more
2 Aug 2018 18:15

DIRECTOR DEALINGS: Proteome Non-Exec Director's Fund Buys Shares

LONDON (Alliance News) - Proteome Science PLC said Thursday that Vulpes Life Sciences Fund, a firm related to a non-executive director Martin Diggle, has bought shares in the company.Diggle

Read more
31 Jul 2018 17:45

DIRECTOR DEALINGS: Fund Linked To Proteome Non-Exec Buys Shares

LONDON (Alliance News) - Proteome Sciences PLC said on Tuesday Vulpes Life Sciences Fund bought shares in the company on Friday.Proteome Non-Executive Martin Diggle is also a director of at

Read more
27 Jul 2018 12:52

Vulpes Buys Proteome Sciences Shares, Raising Joint Director Interest (ALLISS)

LONDON (Alliance News) - Pharmeceutical company Proteome Sciences PLC said Friday that Vulpes Life Sciences Fund purchased 171,000 shares at a price of 2.85 pence per share on in Proteome were up

Read more
24 Jul 2018 10:45

Proteome Shares Drop On Half-Year Performance Behind Expectations

LONDON (Alliance News) - Shares in Proteome Sciences PLC tumbled on Tuesday as the company reported half-year performance "behind expectations".Shares were trading down 11% at for

Read more
24 Jul 2018 08:04

Proteome punished as sales fail to perk up

(Sharecast News) - Proteome Sciences trimmed losses in the first half as the protein biomarker specialist cut costs and revenues stalled.

Read more
30 May 2018 14:58

Proteome Sciences Meeting Expectations Despite Slow First Quarter

LONDON (Alliance News) - Proteome Sciences PLC Chief Executive Officer Jeremy Haigh said Wednesday at the company's annual general meeting trading in the year-to-date has been in line despite

Read more
11 May 2018 08:38

Hargreaves Services Chairman To Step Down, Replacement Named

LONDON (Alliance News) - Hargreaves Services PLC said Friday that David Morgan has decided to step down as chairman and will be succeeded by Roger McDowell.Morgan, who has served as a since

Read more
24 Apr 2018 12:54

Proteome Sciences Appoints Chief Commercial Officer Dennis To Board

LONDON (Alliance News) - Proteome Sciences PLC on Tuesday appointed Chief Commercial Officer Richard Dennis to the board of directors.Dennis joined Proteome in April last year, having as an

Read more
24 Apr 2018 12:11

Proteome Sciences 2017 Loss Narrows On Revenue Growth And Cost Cuts

LONDON (Alliance News) - Life sciences firm Proteome Sciences PLC said Tuesday its annual loss narrowed in 2017 on higher revenue and lower costs, as it looks to focus growth on its biomarker loss

Read more
9 Feb 2017 11:14

Proteome Sciences trades in line as it consolidates lab facilities

(ShareCast News) - Proteome Sciences provided a trading update for the 12 months to 31 December on Thursday, saying that after a strong first half, progress continued throughout the rest of the year with results in line with expectations. The AIM-traded firm said buoyed by robust sales of its TMT re

Read more
9 Feb 2017 09:13

Proteome Sciences Expects Narrowed Loss, Appoints Commercial Officer

Read more
4 Jan 2017 16:48

DIRECTOR DEALINGS: Vehicle Of Proteome Non-Executive Buys Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.